"We've been helping patients in Chicago's Northwest suburbs feel better for over 30 years. In the Lake Barrington office, we treat a full range of urologic conditions such as: Prostate Cancer (from diagnosis to advanced-stage treatment) Female Urinary Incontinence Kidney Stones Erectile Dysfunction Overactive Bladder (OAB) Urinary Retention Enlarged Prostate (BPH) Low Testosterone (Low T) Pelvic Prolapse Hematuria (Blood in urine) Kidney Cancer Bladder Cancer Urinary Tract Infection And perform urology procedures like: Vasectomy Vasectomy Reversal Prostate exams / PSA tests Prostate Cancer Robotic Surgery (prostatectomy) Lithotripsy UroLift for BPH Interstim for OAB Circumcision We treat men, women, adults, & children (pediatric urology)"

During the past decade, Comprehensive Urologic Care conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Urologic Care" #1 sponsor was "Dendreon" with 2 trials, followed by "Bioness Inc" with 1 trials sponsored, "BlueWind Medical" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Myovant Sciences GmbH" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Urologic Care" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Urologic Care" are "Prostate Cancer" (3 trials), "Adenocarcinoma of the Prostate" (1 trials), "Androgen Resistant Prostatic Cancer" (1 trials), "Benign Prostatic Hyperplasia" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Comprehensive Urologic Care" in a lesser frequency.

Most popular intervention types in "Comprehensive Urologic Care" are "Drug" (5 trials), "Device" (3 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (1 trials), "Enzalutamide, Abiraterone" (1 trials), "Leuprolide" (1 trials), "Multiplex-PCR with Pooled Antibiotic Susceptibility Testing (M-PCR/P-AST)" (1 trials) and "Optilume BPH Catheter System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Urologic Care" are 7 trials for "Male" genders, 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Comprehensive Urologic Care". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Comprehensive Urologic Care, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Urologic Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".